Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Individualized treatment of genotype 1 naïve patients: an Italian multicenter field practice experience.

PloS one - 1 Jan 2014

Mangia Alessandra, Cenderello Giovanni, Orlandini Alessandra, Piazzolla Valeria, Picciotto Antonio, Zuin Massimo, Ciancio Alessia, Brancaccio Giuseppina, Forte Paolo, Carretta Vito, Zignego Anna Linda, Minerva Nicola, Brindicci Gaetano, Marignani Massimo, Baroni Gianluca Svegliati, Bertino Gaetano, Cuccorese Giuseppe, Mottola Leonardo, Ripoli Maria, Pirisi Mario

Abstract excerpt

BACKGROUND: Triple therapy including Telaprevir or Boceprevir still represents in many European countries the standard of care for patients with Hepatitis C Virus genotype 1 infection. The number of patients who received this treatment resulted generally lower than expected. We investigated, amon...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Decision Making
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Interferons

Share to Interleukins

Share to Oligopeptides

Share to Precision Medicine

Share to Proline

Source

Open in PubMed Open full text

Identifiers

PMID: 25340799
DOI: 10.1371/journal.pone.0110284
PMCID: PMC4207756

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25340799-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Individualized treatment of genotype 1 naïve patients: an Italian multicenter field practice experience.PMID 25340799Read ↗

Treatment of hepatitis C genotype 1 patients with severe fibrosis or compensated cirrhosis: the telaprevir early access program in patients from RomaniaSemantic proximity Read ↗

Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir.Semantic proximity Read ↗

High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in Spain.Semantic proximity Read ↗

Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver.Semantic proximity Read ↗

Optimising management of patients with hepatitis C virus in the age of direct-acting antivirals: results of a Delphi consensus.Semantic proximity Read ↗

Efficacy and safety of telaprevir (TVR) triple therapy in a 'real-life' cohort of 102 patients with HCV genotype 1: interim analysis after 24 weeks of treatment.Semantic proximity Read ↗

Effectiveness of first-wave protease inhibitors in hepatitis C virus genotype 1 infection: a multicenter study in Brazil.Semantic proximity Read ↗

Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options.Semantic proximity Read ↗

[Triple therapy in cirrhotic patients and those with advanced fibrosis: relevant aspects in clinical practice].Semantic proximity Read ↗

Telaprevir for chronic hepatitis C with genotype 1: a meta-analysis.Semantic proximity Read ↗

Approach to the treatment-experienced patient with hepatitis C virus genotype 1 infection.Semantic proximity Read ↗

Feasibility of individualized treatment for hepatitis C patients in the real world.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.